Search Results - "Patel, BV"

EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy by Manjelievskaia, J, Vaidya, N, Wang, S.M., McDermott, KW, Lavelle, K, Wall, S, Bonafede, M, Patel, BV, Stemple, C, Brixner, D, Malone, D

Get full text

The effect of switching on compliance and persistence: the case of statin treatment by Thiebaud, Patrick, Patel, Bimal V, Nichol, Michael B, Berenbeim, David M

“…To determine the effect of switching drugs on the compliance and persistence of new statin users. Retrospective database analysis of pharmacy claims provided…”
Get full text

PCV97 ANALYSIS ON THE EFFECTS OF MEDICARE PART D COVERAGE GAP ON STATIN MEDICATION ADHERENCE by Pai, J, Zeng, F, Patel, BV, Sanchez, RJ, McCombs, J

Get full text

PCV39 PREDICTING ANTIHYPERTENSIVE DRUG UTILIZATION: AN APPLICATION OF LATENT CLASS MODELS by Thiebaud, P, Patel, BV

Get full text

PCV57 DOES 90-DAY PRESCRIPTION SUPPLY AT RETAIL IMPROVE COMPLIANCE IN A MANAGED CARE SETTING by Thiebaud, P, Patel, BV

Get full text

PDB13 PREDICTING INPATIENT HOSPITALIZATION RISKS FOR MEDICAID DIABETES PATIENTS by Zeng, F, Patel, BV, Gao, S

Get full text

PDB56 THE EFFECT OF VALUE-BASED INSURANCE DESIGN ON ADHERENCE TO DIABETES MEDICATIONS: A MATCHED DIFFERENCE IN DIFFERENCE EVALUATION by Zeng, F, An, JJ, Patel, BV, Scully, R, Barrington, C

Get full text

CM2 UTILIZATION AND PERSISTENCE OF ALISKIREN IN A REAL-WORLD ENVIRONMENT by Zeng, F, Lau, H, Hanson, K, Patel, BV, Gao, S

Get full text

PSN9 PATTERNS OF TOPICAL ACNE PRESCRIPTION MEDICATION USE: ANALYSIS OF A LARGE-SCALE RETROSPECTIVE CLAIMS DATABASE by Hankin, C, Patel, BV, Leslie, S, Gyang, E

Get full text

The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy by Sullivan, Patrick W, Nair, Kavita V, Patel, Bimal V

“…Numerous prescription products have become available over the counter (OTC) in recent years. Previous simulation models have shown the Rx-to-OTC switch of…”
Get full text

Impact of Rofecoxib Withdrawal on Cyclooxygenase-2 Utilization among Patients with and without Cardiovascular Risk by Thiebaud, Patrick, Patel, Bimal V., Nichol, Michael B.

“…To compare how cyclooxygenase-2 (COX-2) users with and without cardiovascular (CV) risks responded to the withdrawal of rofecoxib on September 30, 2004. The…”
Get full text

PMH72 IMPACT OF PHARMACY BENEFIT DESIGN ON ANTI-PSYCHOTIC MEDICATION ADHERENCE AND DISCONTINUATION by Knoth, RL, Chen, CC, Kim, E, Zeng, F, Patel, BV, Leslie, S, Tran, QV, Pikalov, A

Get full text

PMH44 IMPACT OF REJECTED CLAIMS ON PERSISTENCE TO SECOND GENERATION ANTI-PSYCHOTIC MEDICATIONS by Zeng, F, Patel, BV, Kim, E, Knoth, RL, Chen, CC, Tran, QV, Pikalov, A

Get full text

PAL1 THE IMPACT OF THE RX-TO-OTC SWITCH OF LORATADINE AND CHANGES IN PRESCRIPTION DRUG BENEFITS ON UTILIZATION AND COST OF THERAPY by Sullivan, P, Nair, KV, Patel, BV

Get full text

PCV37 PREDICTING STATIN COMPLIANCE IN NEW STARTERS WITH PHARMACY CLAIMS by Thiebaud, P, Nichol, MB, Patel, BV

Get full text

PDB29 THE EFFECT OF INSULIN TREATMENT ON HEALTH CARE UTILIZATION IN TYPE-II DIABETES by Thiebaud, P, Nichol, MB, Patel, BV

Get full text

PAL1 THE IMPACT OF THE RX-TO-OTC SWITCH OF LORATADINE AND CHANGES IN PRESCRIPTION DRUG BENEFITS ON UTILIZATION AND COST OF THERAPY by Sullivan, P, Nair, KV, Patel, BV

Get full text

DU5 IMPACT OF FORMULARY RESTRICTIONS ON ADHERENCE TO SECOND GENERATION ANTIPSYCHOTICS by Zeng, F, Leslie, RS, Patel, BV, Chen, CC, Kim, E, Knoth, R, Tran, QV

Get full text

PIHI5 IMPACT OF BENEFIT DESIGN ON PDE-5 UTILIZATION AND COSTS IN A LARGE PBM DATABASE by Patel, BV, Leslie, RS, Harriett, J, Szczotka, A

Get full text

PDB66 RETROSPECTIVE COMPARISON OF COMPLIANCE TO FIXED-DOSE COMBINATION VERSUS SINGLE AGENT COMBINATION THERAPY FOR THE TREATMENT OF DIABETES by Patel, BV, Leslie, RS, Aranda, GA, McCoy, M, Baran, RW, Xu, Y, Bron, M

Get full text